Biotangents raised £2.3M in a funding round led by Eos and British Business Investments to revolutionize dairy farming with innovative diagnostic technology.
Amount Raised
£2.3 Million
Round Type
Seed
MidlothianBiotechnologyHealth CareInvestors
Description
Biotangents has announced a £2.3 million investment round aimed at enhancing dairy farming with a rapid diagnostic device. The investment, led by Eos and British Business Investments, will support on-farm trials across the UK and internationally.
Quick answer
Biotangents raised £2.3 Million in a Seed round, dated November 28, 2024. Investors: Kelvin Capital, Scottish Enterprise, Eos and British Business Investments. Biotangents is based in Midlothian, Scotland, United Kingdom.
- How much did Biotangents raise?
- Biotangents raised £2.3 Million in a Seed round on November 28, 2024.
- Who invested in Biotangents?
- Kelvin Capital, Scottish Enterprise, Eos and British Business Investments are named as investors in this round.
- What does Biotangents do?
- Biotangents is developing next generation molecular diagnostics for the animal health sector, specifically livestock, to further animal welfare, productivity, sustainability, and food security.
- Where is Biotangents based and how big is it?
- Biotangents is based in Midlothian, Scotland, United Kingdom.
- Who are the decision-makers at Biotangents?
- Fundz holds 1 contact at Biotangents. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Biotangents that raised within 45 days of this round, from Fundz verified event records.
- Windward Bio raised $200M (Series A) on January 10, 2025.
- Ouro Medicine raised $120M (Series A) on January 10, 2025.
- RhyGaze raised $86M (Series A) on January 10, 2025.
- Numab Therapeutics raised $55M (Series C) on January 10, 2025.
- Kardigan raised $300M (Series A) on January 10, 2025.
- Kazia Therapeutics raised $2.1M (Seed) on January 10, 2025.
Who to call at Biotangents, and when
A new round usually means Biotangents is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biotangents raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biotangents, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biotangents. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biotangents raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biotangents raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.